Metabolic syndrome, physical activity and cardiac autonomic function

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 4, 2012, Pages 363-369

  Soares Miranda, Luisa ^a   Sandercock, Gavin ^b   Vale, Susana ^a   Santos, Rute ^a,c   Abreu, Sandra ^a   Moreira, Carla ^a   Mota, Jorge ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF ESSEX   (United Kingdom)

^c RESEARCH CENTER IN SPORTS SCIENCES   (Portugal)

Author keywords

Cardiac autonomic function; Heart rate variability; Inflammation; Metabolic syndrome; Physical activity; Young adults

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; C-REACTIVE PROTEIN; COHORT STUDIES; EXERCISE; HEART RATE; HUMANS; LINEAR MODELS; LIPOPROTEINS, HDL; LONGITUDINAL STUDIES; METABOLIC SYNDROME X; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84860895925     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2281     Document Type: Article

References (43)

1. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26(11): 3153-3159.
2. Vinik AI, Maser RE, Ziegler D. Neuropathy: the crystal ball for cardiovascular disease? Diabetes Care 2010; 33(7): 1688-1690.
3. Vinik AI, Maser RE, Ziegler D. Autonomic imbalance: prophet of doom or scope for hope? Diabet Med 2011; 28(6): 643-651.
4. Lieb DC, Parson HK, Mamikunian G, Vinik AI. Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res 2012; 2012: 878760.
5. Sandercock GR, Brodie DA. The role of heart rate variability in prognosis for different modes of death in chronic heart failure. Pacing Clin Electrophysiol 2006; 29(8): 892-904.
6. Licht CM, Vreeburg SA, van Reedt Dortland AK, et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010; 95(5): 2458-2466.
7. Carnethon MR, Prineas RJ, Temprosa M, Zhang ZM, Uwaifo G, Molitch ME. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care 2006; 29(4): 914-919.
8. Carnethon MR, Jacobs DR Jr, Sidney S, Liu K. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care 2003; 26(11): 3035-3041.
9. Liao D, Sloan RP, Cascio WE, et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998; 21(12): 2116-2122.
10. Koskinen T, Kahonen M, Jula A, et al. Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study. Diabet Med 2009; 26(4): 354-361.
11. Chang CJ, Yang YC, Lu FH, et al. Altered cardiac autonomic function may precede insulin resistance in metabolic syndrome. Am J Med 2010; 123(5): 432-438.
12. Stein PK, Barzilay JI, Domitrovich PP, et al. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study. Diabet Med 2007; 24(8): 855-863.
13. Min KB, Min JY, Paek D, Cho SI. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions. Pacing Clin Electrophysiol 2008; 31(5): 584-591.
14. Gehi AK, Lampert R, Veledar E, et al. A twin study of metabolic syndrome and autonomic tone. J Cardiovasc Electrophysiol 2009; 20(4): 422-428.
15. Hemingway H, Shipley M, Brunner E, Britton A, Malik M, Marmot M. Does autonomic function link social position to coronary risk? The Whitehall II study. Circulation 2005; 111(23): 3071-3077.
16. Sandercock GR, Bromley PD, Brodie DA. Effects of exercise on heart rate variability: inferences from meta-analysis. Med Sci Sports Exerc 2005; 37(3): 433-439.
17. Ekelund U, Anderssen S, Andersen LB, et al. Prevalence and correlates of the metabolic syndrome in a population-based sample of European youth. Am J Clin Nutr 2009; 89(1): 90-96.
18. Bo S, Gentile L, Ciccone G, et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev 2005; 21(6): 515-524.
19. Fallucca F, Pozzilli P. Physical exercise, public health and quality of life in diabetes. Diabetes Metab Res Rev 2009; 25(Suppl 1): S1-S3.
20. Shemesh T, Rowley KG, Shephard M, Piers LS, O'Dea K. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta 2006; 367(1-2): 69-76.
21. Allison MA, Pavlinac P, Wright CM. The differential associations between HDL, non-HDL and total cholesterols and atherosclerotic calcium deposits in multiple vascular beds. Atherosclerosis 2007; 194(2): e87-e94.
22. Esliger DC, Copeland JL, Barnes JD, Tremblay MS. Standardizing and optimizing the use of accelerometer data for free-living physical activity monitoring. J Phys Act Health 2005; 3: 366-383.
23. Freedson PS, Melanson E, Sirard J. Calibration of the Computer Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 1998; 30(5): 777-781.
24. Nunan D, Donovan G, Jakovljevic D, Hodges L, Sandercock G, Brodie D. Validity and reliability of short-term heart-rate variability from the Polar S810. Med Sci Sports Exerc 2009; 41(1): 243-250.
25. Task F. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93(5): 1043-1065.
26. Martinmaki K, Rusko H, Kooistra L, Kettunen J, Saalasti S. Intraindividual validation of heart rate variability indexes to measure vagal effects on hearts. Am J Physiol Heart Circ Physiol 2006; 290(2): H640-H647.
27. Soares-Miranda L, Sandercock G, Valente H, Vale S, Santos R, Mota J. Vigorous physical activity and vagal modulation in young adults. Eur J Cardiovasc Prev Rehabil 2009; 16(6): 705-711.
28. Sandercock GR, Hardy-Shepherd D, Nunan D, Brodie D. The relationships between self-assessed habitual physical activity and non-invasive measures of cardiac autonomic modulation in young healthy volunteers. J Sports Sci 2008; 26(11): 1171-1177.
29. Singh JP, Larson MG, O'Donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000; 86(3): 309-312.
30. Soares-Miranda L, Negrao CE, Antunes-Correa LM, et al. High levels of C-reactive protein are associated with reduced vagal modulation and low physical activity in young adults. Scand J Med Sci Sports 2010. DOI: 10.1111/j.1600-0838.2010.01163.x.
31. Stein PK, Barzilay JI, Chaves PH, et al. Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study. J Am Geriatr Soc 2008; 56(2): 315-321.
32. Madsen T, Christensen JH, Toft E, Schmidt EB. C-reactive protein is associated with heart rate variability. Ann Noninvasive Electrocardiol 2007; 12(3): 216-222.
33. Lampert R, Bremner JD, Su S, et al. Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men. Am Heart J 2008; 156(4): 759, e1-e7.
34. Sloan RP, McCreath H, Tracey KJ, Sidney S, Liu K, Seeman T. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 2007; 13(3-4): 178-184.
35. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25(5): 363-370.
36. Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med 2009; 265(4): 439-447.
37. Araujo F, Antelmi I, Pereira AC, et al. Lower heart rate variability is associated with higher serum high-sensitivity C-reactive protein concentration in healthy individuals aged 46years or more. Int J Cardiol 2006; 107(3): 333-337.
38. von Kanel R, Nelesen RA, Mills PJ, Ziegler MG, Dimsdale JE. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav Immun 2008; 22(4): 461-468.
39. Haarala A, Kahonen M, Eklund C, et al. Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The Cardiovascular Risk in Young Finns Study. Eur J Clin Invest 2011; 41(9): 951-957.
40. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25(1): 4-7.
41. Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 2005; 4(8): 673-684.
42. Tracey KJ. The inflammatory reflex. Nature 2002; 420(6917): 853-859.
43. Carnethon MR, Craft LL. Autonomic regulation of the association between exercise and diabetes. Exerc Sport Sci Rev 2008; 36(1): 12-18.